Status:
UNKNOWN
A Longitudinal Study of the Trajectory of Financial Toxicity and Its Relationship With Symptom Burden in Breast Cancer Patients
Lead Sponsor:
Fudan University
Conditions:
Financial Toxicity
Eligibility:
FEMALE
18+ years
Brief Summary
Breast cancer has become the leading cause of global cancer incidence. With the improvement of treatment methods, some breast cancer patients have experienced different degrees of financial toxicity, ...
Eligibility Criteria
Inclusion
- Diagnosed with breast cancer and underwent surgery
- Be going to receive one or more of chemotherapy, radiotherapy, targeted therapy, endocrine therapy, and immunotherapy
- With the ability to understand and communicate in Chinese
- Provided informed consent
Exclusion
- Illness was considered too severe for participation
- With cognitive or psychiatric disorders
Key Trial Info
Start Date :
November 16 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 31 2024
Estimated Enrollment :
485 Patients enrolled
Trial Details
Trial ID
NCT05964816
Start Date
November 16 2022
End Date
March 31 2024
Last Update
August 1 2023
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Fudan University Shanghai Cancer Center
Shanghai, China
2
The First Hospital of China Medical University
Shenyang, China
3
Wuhan Union Hospital
Wuhan, China
4
Xijing Hospital of the Fourth Military Medical University
Xi'an, China